This new
weight-loss drug is one you want to stay far away from
Diet danger: New drug causes thyroid cancer
Dear Reader,
It looks like Big Pharma is coming at us with a
double-barreled shotgun.
This month, Novo Nordisk, the company that brought us the
dangerous diabetes drug Victoza, has a date with the FDA. It’s all about a deadly new
way to use Victoza.
And you’ll never believe it.
Run for cover
When I read about a “new” drug the FDA is getting ready
to approve, I honestly couldn’t believe my eyes.
It will be called Saxenda — and it’s the same drug
already sold under the name Victoza. But just making a risky med for diabetics
wasn’t enough for this maverick drug maker.
Now it wants to play a deadly deception on innocent
people who are desperate to lose weight.
So what does a horrible drug aimed at diabetics have to
do with a diet pill?
A lot. As in a new way to make a whole lot more money.
In a nutshell, Novo wants to take its deadly diabetes Rx
and repackage it as a weight-loss drug. Its diabolical plan is to find a way to
lure those who don’t even have diabetes into taking it.
I first sent you a warning about Victoza even before the
FDA approved it back in 2010 for diabetics. And just this June, the group
Public Citizen sent another request to the FDA asking that it be banned
immediately.
Public Citizen said that Victoza “puts patients at higher
risk of thyroid cancer, pancreatitis (and) serious allergic reactions.”
Now Victoza’s weight loss “secret” might have something
to do with its side effects. Things like nausea, vomiting and acute diarrhea.
That doesn’t do much for someone’s appetite, now does it?
Long before Victoza was approved by the FDA for type 2,
Novo was secretly scheming to make this deadly twin out of it. The drug company
recruited guinea pigs from around the world to “study” how much weight people
could lose on Victoza.
So it’s no wonder the FDA denied Public Citizen’s
petition. They knew Victoza was coming to town with a new name. So they
couldn’t exactly ban the first one now, could they?
But it gets even worse…
This “new” weight loss drug comes at double the dose!
And, according to Public Citizen’s research, that could mean triple the
risk of pancreatitis. Of course, that didn’t stop Novo or slow down the FDA.
And Novo, which is now focusing on obesity drugs, has
more than just diabetes pills to sell. And wait till you hear about the next
one.
The drug maker told The Wall Street Journal that
there are so many more fat people than diabetics, the market for such meds is
four times the size of that for type 2 drugs! There are close to 100 million
people in the U.S. it said might be candidates for this new drug.
Novo, however, has its eye on more than just that 100
million. Its first target will be those south of the border — in Mexico.
And I’m sure Novo wouldn’t mind at all if docs in this
country started prescribing it “off label” for weight loss right away.
Hopefully, this horribly dangerous drug will come with
the same black box warning as Victoza does about deadly thyroid tumors. And
then there’s that risk of fatal pancreatitis.
As was pointed out in a Novo-funded Victoza study, “The
frequency of obesity has risen dramatically in recent years but only few safe
and effective drugs are currently available.”
And this sure isn’t one of them.
Novo Nordisk
In 2010 Novo Nordisk breached the ABPIs code of
conduct by failing to provide information about side-effects of Victoza and by
promoting Victoza prior to
being granted market authorization.[21]
In 2013 Novo Nordisk had to pay back DKK 3.6 billion to
the Danish tax authorities due to transfer mispricing.[22]
In March 2013, a debate emerged in which scientists
questioned whether the incretin class of diabetes medications – the class to
which Victoza belongs –
had in increased risk of side effects in the pancreas such as pancreatitis and pancreatic
cancer. It was concluded that data currently available did not
confirm these concerns.[23]
In October 2013, batches of NovoMix 30 FlexPen and
Penfill insulin were recalled in some European countries as their analysis had
shown that a small percentage of the products in these batches did not meet the
specifications for insulin strength.
Novo Nordisk
Sidley Austin
LLP was the lobby firm for Novo
Nordisk Inc., and is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma).
Note: Michelle Obama
was a lawyer at Sidley Austin LLP.
Barack
Obama was an intern at Sidley Austin
LLP.
Faith Elizabeth
Gay was an attorney at Sidley Austin LLP, and is a board of
adviser’s member for the American
Constitution Society.
Open
Society Foundations was a funder for the American Constitution Society, the Atlantic Council of the United States (think tank), the Bill, Hillary & Chelsea Clinton
Foundation, and the Carnegie Endowment for International Peace (think
tank).
George
Soros is the founder & chairman for the Open Society Foundations.
Robert Raben was
a director at the American Constitution
Society, and an assistant attorney general for the U.S. Department of Justice.
David B. Barlow
was the U.S. attorney for the District of Utah for the U.S. Department of Justice, and is a partner at Sidley Austin LLP.
Eric H. Holder Jr.
was the attorney general at the U.S.
Department of Justice for the Barack
Obama administration, a board member for the American Constitution Society, is a partner at Covington & Burling LLP, and a member of the Markle Task Force on National Security in
the Information Age.
Covington
& Burling LLP is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma),
and was the lobby firm for Novo Nordisk
Inc.
Lars Rebien
Sorensen is the president & CEO for Novo Nordisk Inc., and was a supervisory board member for Bertelsmann AG.
Markus Dohle is
an executive board member for Bertelsmann AG, and was a director at
the Atlantic Council of the United
States (think tank).
Elizabeth
Frawley Bagley is a director at the Atlantic
Council of the United States (think tank), and was a funder for the Bill, Hillary & Chelsea Clinton
Foundation.
American
Cancer Society was a funder for the Bill,
Hillary & Chelsea Clinton Foundation.
Margaret A.
Hamburg is a member of the Markle
Task Force on National Security in the Information Age, the VP for the Nuclear Threat Initiative (think tank),
and was a commissioner for the U.S. Food
and Drug Administration (FDA).
Jessica Tuchman Mathews is a director at the Nuclear Threat Initiative (think tank),
was the president of the Carnegie Endowment for International Peace (think
tank), a director at the American Friends of Bilderberg (think
tank), an honorary trustee at the Brookings Institution (think tank), and
a 2008 Bilderberg conference participant (think tank).
Ed Griffin’s interview with Norman Dodd in 1982
(The investigation into the Carnegie Endowment for
International Peace uncovered the plans for population control by involving the
United States
in war)
Carnegie
Endowment for International Peace (think
tank) was a funder for the Nuclear
Threat Initiative (think tank).
Donald Kennedy
was a trustee at the Carnegie Endowment
for International Peace (think tank), and a commissioner for the U.S. Food and Drug Administration (FDA).
Open
Society Foundations was a funder for the Carnegie Endowment for International
Peace (think tank).
George
Soros is the founder & chairman for the Open Society Foundations, and was the chairman for the Foundation
to Promote Open Society.
Foundation
to Promote Open Society was a funder for the Brookings Institution
(think tank).
Robert A. Helman
was an honorary trustee at the Brookings Institution (think tank), and
is a partner at Mayer Brown.
Mayer Brown was
the lobby firm for Bertelsmann AG,
and is the lobby firm for the Bayer
Corporation.
Lars Rebien
Sorensen was a supervisory board member for Bertelsmann AG, and is the president & CEO for Novo Nordisk Inc.
Bayer
Corporation is a North American subsidiary of Bayer AG.
An aspirin a day... causes blindness?
Bayer AG - World War I and
II
During World War II, IG Farben used slave labor
in factories attached to large slave labor camps, notably I.G. Auschwitz,[23] and the
sub-camps of the Mauthausen-Gusen concentration camp.[24]
IG Farben engaged in human experimentation on Auschwitz prisoners, often with
fatal results.[25] After World War II,
the Allies broke up IG Farben and Bayer reappeared
as an individual business. IG Farben board member Fritz ter Meer,
sentenced to seven years in prison during the IG Farben
Military Tribunal at Nuremberg, was elected Bayer's supervisory
board head in 1956.
Bayer HealthCare
is a subsidiary of Bayer AG.
Sidley Austin
LLP is the lobby firm for Bayer
HealthCare, the Pharmaceutical
Research and Manufacturers of America (Big Pharma), and was the lobby firm
for Novo Nordisk Inc.
Barack
Obama was an intern at Sidley Austin
LLP.
No comments:
Post a Comment